These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 1556045

  • 21. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB.
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [Abstract] [Full Text] [Related]

  • 22. Intravesical bacillus Calmette-Guèrin for the treatment of superficial bladder cancer in renal transplant patients.
    Palou J, Angerri O, Segarra J, Caparrós J, Guirado L, Diaz JM, Salvador-Bayarri J, Villavicencio-Mavrich H.
    Transplantation; 2003 Nov 27; 76(10):1514-6. PubMed ID: 14657696
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts.
    Palou Redorta J, Schatteman P, Huguet Pérez J, Segarra Tomás J, Rosales Bordes A, Algaba F, Villavicencio Mavrich H.
    Eur Urol; 2006 May 27; 49(5):834-8; discussion 838. PubMed ID: 16426729
    [Abstract] [Full Text] [Related]

  • 25. [Intravesical BCG therapy for superficial bladder cancer].
    Segawa N, Iwamoto Y, Azuma H, Yamamoto K, Ueda H, Katsuoka Y.
    Hinyokika Kiyo; 1998 Sep 27; 44(9):627-31. PubMed ID: 9805666
    [Abstract] [Full Text] [Related]

  • 26. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ, Shen ZJ, Lu J, Jin XD, Chen J, Shi SF.
    Zhonghua Wai Ke Za Zhi; 2005 Nov 15; 43(22):1457-60. PubMed ID: 16318813
    [Abstract] [Full Text] [Related]

  • 27. [Efficacy of intravesical bacillus Calmette-Guerin for carcinoma in situ of bladder].
    Uekado Y, Kohjimoto Y, Iba A, Kikkawa K, Shintani Y, Shinka T.
    Hinyokika Kiyo; 2006 Jun 15; 52(6):439-44. PubMed ID: 16848357
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. When intravesical measures fail. Indications for cystectomy in superficial disease.
    Hudson MA.
    Urol Clin North Am; 1992 Aug 15; 19(3):601-9. PubMed ID: 1636242
    [Abstract] [Full Text] [Related]

  • 32. Intravesical chemotherapy. Treatment selection, techniques, and results.
    Richie JP.
    Urol Clin North Am; 1992 Aug 15; 19(3):521-7. PubMed ID: 1636236
    [Abstract] [Full Text] [Related]

  • 33. [Cases of bacillus Calmette-Guerin-induced granulomatous prostatitis and prostatic stromal invasion of the bladder carcinoma in situ, showing similar clinical findings].
    Okusa H, Irie A, Chin I, Baba S, Mitomi H, Shitara T.
    Hinyokika Kiyo; 2003 Sep 15; 49(9):555-7. PubMed ID: 14598697
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
    Friedrich MG, Pichlmeier U, Schwaibold H, Conrad S, Huland H.
    Eur Urol; 2007 Oct 15; 52(4):1123-29. PubMed ID: 17383080
    [Abstract] [Full Text] [Related]

  • 36. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials.
    Han RF, Pan JG.
    Urology; 2006 Jun 15; 67(6):1216-23. PubMed ID: 16765182
    [Abstract] [Full Text] [Related]

  • 37. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998 Jun 15; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 38. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P, Lugagne PM, Botto H.
    J Urol; 2000 Jan 15; 163(1):63-7. PubMed ID: 10604315
    [Abstract] [Full Text] [Related]

  • 39. Introduction and overview of intravesical therapy for superficial bladder cancer.
    Soloway MS.
    Urology; 1988 Mar 15; 31(3 Suppl):5-16. PubMed ID: 3126593
    [Abstract] [Full Text] [Related]

  • 40. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.
    Böhle A, Bock PR.
    Urology; 2004 Apr 15; 63(4):682-6; discussion 686-7. PubMed ID: 15072879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.